Stock Track | Insilico Medicine Plummets 6.49% Intraday as Abu Dhabi Secondary Listing Hopes Fade and Lock-Up Expiry Looms

Stock Track06-01

Insilico Medicine's stock plunged 6.49% during intraday trading, extending recent losses as the company faces dual pressures from dashed market expectations and approaching shareholder lock-up expirations.

The decline follows the company's voluntary announcement clarifying it currently has no definite plans for a secondary listing in Abu Dhabi, disappointing investors who had anticipated such a move would broaden the company's international financing channels and deepen its Middle East strategic positioning.

Additionally, having listed on the Hong Kong Stock Exchange in December last year, Insilico Medicine has now entered the June lock-up expiry window, with certain cornerstone investors and employee option restricted shares approaching their release dates. Market concerns over potential selling pressure from these unlocked shares have intensified disposal activity, contributing to the stock's downward trajectory.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196706637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 10:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196706637","market":"us","top_or_hot":-1,"title":"Stock Track | Insilico Medicine Plummets 6.49% Intraday as Abu Dhabi Secondary Listing Hopes Fade and Lock-Up Expiry Looms","media":"Stock Track","content":"<p>Insilico Medicine's stock plunged 6.49% during intraday trading, extending recent losses as the company faces dual pressures from dashed market expectations and approaching shareholder lock-up expirations.</p><p>The decline follows the company's voluntary announcement clarifying it currently has no definite plans for a secondary listing in Abu Dhabi, disappointing investors who had anticipated such a move would broaden the company's international financing channels and deepen its Middle East strategic positioning.</p><p>Additionally, having listed on the Hong Kong Stock Exchange in December last year, Insilico Medicine has now entered the June lock-up expiry window, with certain cornerstone investors and employee option restricted shares approaching their release dates. Market concerns over potential selling pressure from these unlocked shares have intensified disposal activity, contributing to the stock's downward trajectory.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Insilico Medicine Plummets 6.49% Intraday as Abu Dhabi Secondary Listing Hopes Fade and Lock-Up Expiry Looms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Insilico Medicine Plummets 6.49% Intraday as Abu Dhabi Secondary Listing Hopes Fade and Lock-Up Expiry Looms\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-01 10:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Insilico Medicine's stock plunged 6.49% during intraday trading, extending recent losses as the company faces dual pressures from dashed market expectations and approaching shareholder lock-up expirations.</p><p>The decline follows the company's voluntary announcement clarifying it currently has no definite plans for a secondary listing in Abu Dhabi, disappointing investors who had anticipated such a move would broaden the company's international financing channels and deepen its Middle East strategic positioning.</p><p>Additionally, having listed on the Hong Kong Stock Exchange in December last year, Insilico Medicine has now entered the June lock-up expiry window, with certain cornerstone investors and employee option restricted shares approaching their release dates. Market concerns over potential selling pressure from these unlocked shares have intensified disposal activity, contributing to the stock's downward trajectory.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1196706637","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196706637","pubTimestamp":1780279897,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Insilico Medicine's stock plunged 6.49% during intraday trading, extending recent losses as the company faces dual pressures from dashed market expectations and approaching shareholder lock-up...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"个股追踪|英矽智能盘中暴跌6.49%阿布扎比二次上市希望消退禁售期临近","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine's stock plunged 6.49% during intraday trading, extending recent losses as the company faces dual pressures from dashed market expectations and approaching shareholder lock-up expirations.The decline follows the company's voluntary announcement clarifying it currently has no definite plans for a secondary listing in Abu Dhabi, disappointing investors who had anticipated such a move would broaden the company's international financing channels and deepen its Middle East strategic positioning.Additionally, having listed on the Hong Kong Stock Exchange in December last year, Insilico Medicine has now entered the June lock-up expiry window, with certain cornerstone investors and employee option restricted shares approaching their release dates. Market concerns over potential selling pressure from these unlocked shares have intensified disposal activity, contributing to the stock's downward trajectory.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196706637","isCrawlerRequest":true}